MR-guided, daily adjusted radiation therapy on a CT-guided radiation device for the precise treatment of ultra-central lung tumors
Descrizione riassuntiva dello studio
You are suffering from a tumor or metastasis that is very close to the central structures within the lung (airway and/or esophagus, main bronchi), also referred to as an 'ultra-central lung tumor.' As a result, it has been recommended to perform a highly precise, so-called 'stereotactic' radiation therapy. In this study, we investigate whether daily adjusted radiation therapy using a special MR simulator and CT-guided radiation is feasible for treating such ultra-central lung tumors and whether it offers advantages over standard, non-daily adjusted radiation therapy. The common type of radiation therapy is CT-based radiation therapy: before the first radiation session, magnetic resonance (MR) or computed tomography (CT) imaging is performed. Based on this imaging, the radiation therapy is planned. All radiation sessions are then conducted according to this plan. A computed tomography scanner is integrated into the radiation device, allowing three-dimensional images to be recorded for patient positioning. In the context of daily adjusted radiation therapy, an imaging (MR imaging) is performed using an MR simulator before each radiation session. The radiation plan is then adjusted according to the imaging. Individual anatomy is subject to daily (usually small) changes, such as a decrease in tumor volume during radiation therapy, the position of the esophagus/airway relative to each other, etc. With daily adjusted radiation therapy, the radiation plan can be immediately adapted to these changes just before each radiation session. This is expected to lead to more precise targeting of the tumor while better sparing surrounding organs compared to solely CT-based radiation therapy.
(BASEC)
Intervento studiato
Preparation: Before starting radiation, we perform MR imaging in the same position intended for radiation using two special MR simulators with different field strengths (MR simulation). Based on this imaging, we create your baseline radiation plan. It takes about a week to create the baseline radiation plan.
Radiation therapy: On each radiation day, MR simulation is performed again. A new radiation plan is then created based on the latest MR imaging. If this radiation plan meets the quality requirements, you will be treated on the same day with a CT-guided radiation device according to the new radiation plan. If the day's radiation plan does not meet the quality criteria, treatment can still proceed: you will receive therapy according to the original plan created during the first MR simulation, so the radiation series does not have to be interrupted. Once a week, the treatment takes a bit longer because we perform a second MR scan that provides additional information about changes in the tumor and surrounding healthy tissue under radiation.
Follow-up: The follow-up care for study participants after completing radiation therapy corresponds to the current clinical standard and is not altered by the study.
(BASEC)
Malattie studiate
Ultra-central lung cancer
(BASEC)
1) 18 years or older 2) Tumor or metastasis that is very close to the central structures within the lung (airway and esophagus, main bronchi), also referred to as an 'ultra-central lung tumor.' 3) Indication for highly precise, so-called 'stereotactic' radiation therapy (based on a recommendation from a multidisciplinary tumor board and/or a clinical practice guideline). (BASEC)
Criteri di esclusione
1) Contraindications for MR (including but not limited to electronic devices such as pacemakers, defibrillators, deep brain stimulators, cochlear implants that are labeled as MR-unsafe, metallic foreign bodies in the eye; severe claustrophobia; hip prostheses that are labeled as MR-unsafe) 2) Previous radiation therapy that directly overlaps with the planned highly precise, so-called 'stereotactic' radiation therapy 3) Pregnant or breastfeeding women, as well as women and men who do not wish to use an effective contraceptive method. (BASEC)
Luogo dello studio
Zurigo
(BASEC)
Sponsor
Universitätsspital Zürich Klinik für Radio-Onkologie
(BASEC)
Contatto per ulteriori informazioni sullo studio
Persona di contatto in Svizzera
Dr. med. Lena Kretzschmar
+41 44 255 35 66
Lena.Kretzschmar@clutterusz.chUniversitätsspital Zürich Klinik für Radio-Onkologie
(BASEC)
Informazioni scientifiche
non disponibile
Nome del comitato etico approvante (per studi multicentrici solo il comitato principale)
Commissione etica Zurigo
(BASEC)
Data di approvazione del comitato etico
11.07.2025
(BASEC)
ID di studio ICTRP
non disponibile
Titolo ufficiale (approvato dal comitato etico)
MR-informed stereotactic radiotherapy for treatment of ultracentral lung tumours utilising a dedicated MR-simulator for daily adaptation followed by CBCT-guided treatment delivery (MUSIC) (BASEC)
Titolo accademico
non disponibile
Titolo pubblico
non disponibile
Malattie studiate
non disponibile
Intervento studiato
non disponibile
Tipo di studio
non disponibile
Disegno dello studio
non disponibile
Criteri di inclusione/esclusione
non disponibile
non disponibile
Endpoint primari e secondari
non disponibile
non disponibile
Data di registrazione
non disponibile
Inclusione del primo partecipante
non disponibile
Sponsor secondari
non disponibile
Contatti aggiuntivi
non disponibile
ID secondari
non disponibile
Risultati-Dati individuali dei partecipanti
non disponibile
Ulteriori informazioni sullo studio
non disponibile
Risultati dello studio
Riepilogo dei risultati
non disponibile
Link ai risultati nel registro primario
non disponibile